Linker-specific monoclonal antibodies present a simple and reliable detection method for scFv-based CARNK cells
Katharina Schindler, Katharina Eva Ruppel, Claudia Müller, Ulrike Koehl et al. • Molecular Therapy: Methods & Clinical Development
(2024)
Chimeric antigen receptor (CAR) T cell therapies have demonstrated significant successes in treating cancer. Currently, there are six approved CAR T cell products available on the market that target different malignancies of the B cell line...
DOAJ
Open Access (DOAJ)
DOI:
10.1016/j.omtm.2024.101328